Page 66 - GPD-3-3

Gene & Protein in Disease Amino acid metabolism in neurodegeneration

15. Traxler L, Lagerwall J, Eichhorner S, et al. 27. Pickrell AM, Youle RJ. The roles of PINK1, parkin, and
Metabolism navigates neural cell fate in development, mitochondrial fidelity in Parkinson’s disease. Neuron.
aging and neurodegeneration. Dis Model Mech. 2015;85(2):257-273.
2021;14(3):dmm048993.
doi: 10.1016/j.neuron.2014.12.007
doi: 10.1242/dmm.048993
28. Delamarre A, Meissner WG. Epidemiology, environmental
16. Tatapudy S, Aloisio F, Barber D, Nystul T. Cell fate decisions: risk factors and genetics of Parkinson’s disease. Presse Med.
Emerging roles for metabolic signals and cell morphology. 2017;46(2):175-181.
EMBO Rep. 2017;18(12):2105-2118. doi: 10.1016/j.lpm.2017.01.001
doi: 10.15252/embr.201744816 29. Simon DK, Tanner CM, Brundin P. Parkinson disease

17. Spinelli JB, Haigis MC. The multifaceted contributions epidemiology, pathology, genetics, and pathophysiology.
of mitochondria to cellular metabolism. Nat Cell Biol. Clin Geriatr Med. 2020;36(1):1-12.
2018;20(7):745-754. doi: 10.1016/j.cger.2019.08.002

doi: 10.1038/s41556-018-0124-1 30. Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat
18. Johnson MA, Vidoni S, Durigon R, et al. Amino acid Rev Dis Primers. 2017;3:17013.
starvation has opposite effects on mitochondrial and doi: 10.1038/nrdp.2017.13
cytosolic protein synthesis. PLoS One. 2014;9(4):e0093597.
31. Evans SJW, Douglas I, Rawlins MD, Wexler NS, Tabrizi SJ,
doi: 10.1371/journal.pone.0093597 Smeeth L. Prevalence of adult Huntington’s disease in the
19. Grzegorski T, Losy J. Multiple sclerosis - the remarkable UK based on diagnoses recorded in general practice records.
story of a baffling disease. Rev Neurosci. 2019;30(5):511-526. J Neurol Neurosurg Psychiatry. 2013;84(10):1156-1160.
doi: 10.1515/revneuro-2018-0074 doi: 10.1136/jnnp-2012-304636
20. Jamebozorgi K, Rostami D, Pormasoumi H, Taghizadeh E, 32. Ross CA, Aylward EH, Wild EJ, et al. Huntington disease:
Barreto GE, Sahebkar A. Epigenetic aspects of multiple Natural history, biomarkers and prospects for therapeutics.
sclerosis and future therapeutic options. Int J Neurosci. Nat Rev Neurol. 2014;10(4):204-216.
2021;131(1):56-64. doi: 10.1038/nrneurol.2014.24
doi: 10.1080/00207454.2020.1732974 33. Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington
21. Kumar G, Axtell RC. Dual role of b cells in multiple sclerosis. disease: New insights into molecular pathogenesis and
Int J Mol Sci. 2023;24(3):2336. therapeutic opportunities. Nat Rev Neurol. 2020;16(9):
529-546.
doi: 10.3390/ijms24032336
doi: 10.1038/s41582-020-0389-4
22. Wingerchuk DM, Carter JL. Multiple sclerosis: Current
and emerging disease-modifying therapies and treatment 34. Weskamp K, Barmada SJ. TDP43 and RNA instability in
strategies. Mayo Clin Proc. 2014;89(2):225-240. amyotrophic lateral sclerosis. Brain Res. 2018;1693:67-74.
doi: 10.1016/j.mayocp.2013.11.002 doi: 10.1016/j.brainres.2018.01.015
23. Vargas DL, Tyor WR. Update on disease-modifying therapies 35. Chou CC, Zhang Y, Umoh ME, et al. TDP-43 pathology
for multiple sclerosis. J Investig Med. 2017;65(5):883-891. disrupts nuclear pore complexes and nucleocytoplasmic
transport in ALS/FTD. Nat Neurosci. 2018;21(2):228-239.
doi: 10.1136/jim-2016-000339
doi: 10.1038/s41593-017-0047-3
24. Gouras GK, Olsson TT, Hansson O. β-Amyloid peptides and
amyloid plaques in Alzheimer’s disease. Neurotherapeutics. 36. Steyaert J, Scheveneels W, Vanneste J, et al. FUS-induced
2015;12(1):3-11. neurotoxicity in Drosophila is prevented by downregulating
nucleocytoplasmic transport proteins. Hum Mol Genet.
doi: 10.1007/s13311-014-0313-y 2018;27(23):4103-4116.
25. Morris GP, Clark IA, Vissel B. Inconsistencies and doi: 10.1093/hmg/ddy303
controversies surrounding the amyloid hypothesis of 37. Salameh JS, Brown RH, Berry JD. Amyotrophic lateral
Alzheimer’s disease. Acta Neuropathol Commun. 2014;2:135.
sclerosis: Review. Semin Neurol. 2015;35(5):469-476.
doi: 10.1186/s40478-014-0135-5
doi: 10.1055/s-0035-1558984
26. Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 38. Eelen G, de Zeeuw P, Treps L, Harjes U, Wong BW,
2020;27(1):27-42.
Carmeliet P. Endothelial cell metabolism. Physiol Rev.
doi: 10.1111/ene.14108 2018;98(1):3-58.

Volume 3 Issue 3 (2024) 12 doi: 10.36922/gpd.3294